Low and Conventional Dose of Somatropin in Growth Hormone Deficient Adult Patients
Status:
Completed
Trial end date:
1998-12-01
Target enrollment:
Participant gender:
Summary
An international study in which patients with GHD were randomized to receive somatropin at a
dose of either 3 microg/kg/day or 6 microg/kg/day for the first three months. The dose was
then doubled (6 microg/kg/day, LD or 12 microg/kg/day, CD) for the next three-months.
Phase:
Phase 3
Details
Lead Sponsor:
Eli Lilly and Company
Collaborators:
University of Milan University of Naples University of Padova University of Padua University of Pisa